Oriza Seed Capital (Oriza Yuandian)

Oriza Seed Capital (Oriza Yuandian)

This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Headquarters Location

China, Suzhou

About

The the headquarters of this VC is in Suzhou. The VC's location is in Asia, China.

The average start-up valuation at the time of investment from Oriza Seed Capital (Oriza Yuandian) is 500 millions - 1 billion dollars. Deals in the range of 10 - 50 millions dollars are most common for this fund. In real terms, this VC performs 16 percentage points more exits than other funds. Oriza Seed Capital (Oriza Yuandian) is involved in 22 percentage points less than the average amount of lead investments when compared with other funds. The fund typically enters into 2-6 deals annually. The highest number of exits from this fund were in 2019. In 2019, the fund's activity was at its peak.

The fund typically invests in rounds with 3-4 participants. Along with Oriza Seed Capital (Oriza Yuandian), start-ups are often financed by YuanMing Capital, Yonghua Capital, WuXi Healthcare Ventures. The fund often co-invests with YuanMing Capital, Yonghua Capital, TF Capital, overall with 5 funds from our list. In subsequent rounds, the fund is usually supported by YuanMing Capital, SDIC Venture Capital, Yonghua Capital.

The overall number of key employees in the fund's team is 2.

The country of its foundation and the country of the most frequent investments for the fund coincides - China. The average start-up age at the time of investment by this fund is 2-3. Cambricon, CStone Pharmaceuticals, JW Therapeutics are among the most popular portfolio start-ups of the fund. The fund has an exact preference in the amount of founders of companies in its portfolio. We can highlight the most popular investment areas for this fund, such as Biopharma, Health Care. In addition, there are 10 more industries where it has achieved success.

Fund Activity

Operative

Mail Rule [rules by which you can get an email of an interesting for you fund employee, knowing only the name and surname of this employee]

Domain name: m12.vc; User name format in descending order of probability: first '.' last

Group Appearance [how often fund is operating separately from groups with shared interest]

90.9% of cases

Follow-on Index [how often fund is ready to support its portfolio startup at next rounds]

16.7% of cases

Average Multiplicator [the average ratio of the last valuation of portfolio startups to their total amount of financing raised]

x4

Average Portfolio Company
Exit Age [the average age of portfolio startups at which they go public or become acquired]

6.9 years

Success / Strategy Similarity
Index [the matching between fund's investment strategy and its proved successes in the form of portfolio startups high valuations]

0.1 out of 1

Number of Unicorns [amount of portfolio companies, which were valuated at more then $1B]

2

Funds Investing in Previous
Rounds

YuanMing Capital, Yonghua Capital, WuXi Healthcare Ventures

Funds Investing Together

YuanMing Capital, Yonghua Capital, TF Capital

Funds Investing in Following
Rounds

YuanMing Capital, SDIC Venture Capital, Yonghua Capital

If you have found a spelling error or the data isn't actual, please, notify us by selecting that text and pressing Ctrl+Enter.

Fund reviews
  • No reviews are submitted yet.
Crunchbase icon

Content report

The following text will be sent to our editors: